Skip to content
All Updates
- Decisions of 51st Meeting of Medical Device Board (Deficiency letters Local/Import)December 5, 2022
- Minutes of 288th Meeting of Central Licensing Board held on 18th October 2022December 2, 2022
- Recall Alert: Drug Product; Ximex 100mg/5mL Suspension by Farmaceutics International KarachiDecember 1, 2022
- Recall Alert: Drug Product; Kempol 120ml/5mL Pediatric Syrup by M/s Alkemy Pharmaceutical Laboratories Pvt Ltd HyderabadDecember 1, 2022
- Rapid Alert: Drug Product; Falsified Restane Inhalational Solution Identified and ConfiscatedDecember 1, 2022
- Rapid Alert: Drug Product; Falsified Tablin 300mg Capsule identified in the marketNovember 30, 2022
- Recall Alert: Drug Product; Ponstan Forte 500mg Tablets (Batch # 2050533) by M/s Pfizer Pakistan Ltd, Karachi.November 30, 2022
- Recall Alert: Drug Product; Diamicron 80mg Tablets (Batch#1740) by M/s. Servier Research & Pharmaceuticals Pakistan (Pvt) Ltd Lahore.November 29, 2022
- Drug Safety Alert: Risk of Kidney Injury and Death due to Hydroxyethyl-Starch Solutions for Infusion.November 29, 2022
- Drug Safety Alert: Increased Risk of Cardiovascular Events with Co-administration and Interaction Between Hydroxychloroquine or Chloroquine, and Macrolide AntibioticsNovember 29, 2022
- Drug Safety Alert: Risk of Major Congenital Malformations with PregabalinNovember 29, 2022
- Rapid Alert: Drug Product; Falsified Xanax 0.5mg Tablets identified in the marketNovember 29, 2022
- DRAP finalized guidelines on Post Registration Variations of Pharmaceutical and Biological Drug ProductsNovember 27, 2022
- Drug Safety Alert: Risk of Reduced Vitamin B12 Level with Metformin and Metformin-Containing MedicinesNovember 25, 2022
- Drug Safety Alert: Risk of Severe Cutaneous Adverse Reactions (SCARs) with AtezolizumabNovember 25, 2022
- Stakeholder Comments are invited on the Draft Therapeutic Goods (Federal Inspectors, Laboratories and Federal Government Analysts) Rules, 2022November 24, 2022
- Drug Safety Update: Risk of Hypothyroidism in Babies and Young Children with Iodinated Contrast Media (ICM) InjectionsNovember 24, 2022
- DRAP invited Comments from Stakeholders on the Draft Therapeutic Goods (Advertisement) Rules, 2022November 22, 2022
- Drug Safety Update; PRAEC issued a Safety Alert on Risk of Sinus Bradycardia with RemdesivirNovember 21, 2022
- Drug Safety Update: Risk of Infusion-Related Hypersensitivity Reactions with RemdesivirNovember 18, 2022
- Drug Safety Alert: Risk of Serious Bowl complications with clozapineNovember 18, 2022
- Drug Safety Alert: Risk of Anaphylactic Reaction / Anaphylactic Shock with Diclofenac Sodium InjectionNovember 18, 2022
- Medicine Safety Week 2022; DRAP’s Call to Healthcare Professionals and Patients to Report Suspected Adverse Reactions of drugs and vaccines.November 14, 2022
- DRAP Signed MoU with Pakistan Single Window to Foster CooperationNovember 12, 2022
- Recall Alert: Drug Product; Moxtrex 400mg Tablets (Batch # 850) by M/s Gillman Pharmaceuticals, Hattar, Khyber PakhtunkhwaNovember 7, 2022
- Recall Alert: Drug Product; Ceficure 400mg Capsules (Batch # C-737) by M/s Max Pharmaceuticals IslamabadNovember 4, 2022
- Recall Alert: Drug Product; Telsarta 40mg Tablets (Batch # 2B151) by M/s PharmEvo Pharmaceuticals Pvt Ltd. KarachiNovember 4, 2022
- Expression of Interest from hospitals for medical treatmentNovember 4, 2022
- Notification – SRO 1995(I)/2022 MRP of ParacetamolNovember 4, 2022
- Minutes of 1st Meeting of Pharmacovigilance Risk Assessment Expert Committee (PRAEC) held on 12-October, 2022November 3, 2022
- Suspected Falsified Alert; Drug Products; Suspected Anti-D Immunoglobulin Injection in the marketOctober 31, 2022
- Regulatory Update / Advisory; Recall of Targocid 200mg powder for solution for injection/infusion or oral solution in UKOctober 31, 2022
- Decisions of 50th meeting of Medial Device Board (Deficiency letters Local/Import)October 28, 2022
- DRAP finalizes Guidelines on the Preparation of Summary of Product Characteristics (SmPC)October 27, 2022
- Minutes of 321st meeting of Registration Board held on 20th to 22nd September, 2022October 26, 2022
- Suspected Falsified Alert; Drug Products; Regulatory Field Force reported the presence of suspected falsified products in marketOctober 26, 2022
- Drug Impurity Alert ! Compulsory Testing of Solvents Glycerin, Propylene Glycol & Sorbitol used in Oral Preparations for Presence of any Toxic Impurities (e.g. Diethylene Glycol (DEG) & Ethylene Glycol (EG).October 21, 2022
- Recall Alert: Drug Product; Sterile Water for Injection (Batch # 440) By M/s. Karachi Pharmaceutical Laboratories, KarachiOctober 21, 2022
- Usage of online account for DRAP E-services(Pharma industry)October 21, 2022
- Notification: Applications for Registrations of Pharmaceutical drugs submitted on Form 5/5D requiring submission of Product Stability DataOctober 17, 2022
- SRO 1888(I)/2022 : Notification of Clinical Studies Committee under Bio-Study Rules, 2017October 13, 2022
- WHO Global Alert on Contaminated Pediatrics Cough Syrups Identified In Gambia-West AfricaOctober 12, 2022
- Recall Alert: Drug Product; Human Albumin 20% 100mL (Batch/Lot # C236821P02) Manufactured By M/s. Biotest Pharma GmbHOctober 7, 2022
- Recall Alert: Drug Product; Fentos 50mg Tablets (Batch # 599) By M/s. Hisun Pharmaceutical Industries, Gadoon-PakistanOctober 6, 2022
- Recall Alert; Drug Product: Pantoloon 20mg Tablets (Batch # 5611) By M/S. Rock Pharmaceutical Laboratories (Pvt.) Ltd. RisalpurOctober 6, 2022
- Recall Alert; Drug Product: Zatranex 50mg/mL injection (Batch # 622) by M/s. Zafa Pharmaceutical Laboratories (Pvt.) Ltd., Karachi.October 6, 2022
- Decisions of 49th meeting of Medial Device Board (Deficiency letters Local/Import)October 4, 2022
- 110th Meeting of Enlistment Evaluation Committee (EEC); Notice for Submission of Deficient Information / DocumentsSeptember 30, 2022
- 109th Meeting of Enlistment Evaluation Committee (EEC); Notice for Submission of Deficient Information / DocumentsSeptember 30, 2022
- 108th Meeting of Enlistment Evaluation Committee (EEC); Notice for Submission of Deficient Information / DocumentsSeptember 30, 2022
